Korean large business groups should turn to world pharmaceutical market: local seminar

Published: 2004-06-24 06:58:00

Updated: 2004-06-24 06:58:00

Amid the situation that Korea's pharmaceutical market size is estimated at 8 trillion won and its R&D investment hovers at 4 percent to 300 billion won, Korean conglomerates should make massive amount of R&D investment for the development of blockbuster drugs towards the global market of about 50...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK